These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Digoxin as a treatment for patients with idiopathic intracranial hypertension. Haagensen J; Hoegerl C J Am Osteopath Assoc; 2014 Mar; 114(3):213-5. PubMed ID: 24567274 [TBL] [Abstract][Full Text] [Related]
10. Benign intracranial hypertension without papilledema: case report. Scanarini M; Mingrino S; d'Avella D; Della Corte V Neurosurgery; 1979 Sep; 5(3):376-7. PubMed ID: 503301 [TBL] [Abstract][Full Text] [Related]
12. Early-developed hand osteoarthritis in treated HIV-positive patients: Four cases. Larcher R; Mauboussin JM; Rouanet I; Sotto A Joint Bone Spine; 2015 Oct; 82(5):365-7. PubMed ID: 26184535 [TBL] [Abstract][Full Text] [Related]
13. [Drug-induced benign intracranial hypertension. Apropos of a case with amphotericin B. Review of the literature]. Heudier P; Chichmanian RM; Taillan B; Gratecos N; Fuzibet JG; Dujardin P Therapie; 1992; 47(5):403-7. PubMed ID: 1299980 [TBL] [Abstract][Full Text] [Related]
14. Chronic daily headache with migrainous features due to papilledema-negative idiopathic intracranial hypertension. Huff AL; Hupp SL; Rothrock JF Cephalalgia; 1996 Oct; 16(6):451-2. PubMed ID: 8902257 [TBL] [Abstract][Full Text] [Related]
15. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial. Dinkin MJ; Patsalides A J Neuroophthalmol; 2017 Jun; 37(2):113-121. PubMed ID: 27556959 [TBL] [Abstract][Full Text] [Related]
16. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension. Huang-Link YM; Al-Hawasi A; Oberwahrenbrock T; Jin YP Clin Neurol Neurosurg; 2015 Mar; 130():122-7. PubMed ID: 25614195 [TBL] [Abstract][Full Text] [Related]
17. The relationship between idiopathic intracranial hypertension and obesity. Hannerz J; Ericson K Headache; 2009 Feb; 49(2):178-84. PubMed ID: 19222591 [TBL] [Abstract][Full Text] [Related]
18. Delayed onset of pseudotumor cerebri syndrome 7 years after starting human recombinant growth hormone treatment. Vischi A; Guerriero S; Giancipoli G; Lorusso V; Sborgia G Eur J Ophthalmol; 2006; 16(1):178-80. PubMed ID: 16496267 [TBL] [Abstract][Full Text] [Related]